Literature DB >> 7425890

Abetalipoproteinemia. Report of two cases and review of therapy.

D R Illingworth, W E Connor, R G Miller.   

Abstract

The clinical presentation and course of abetalipoproteinemia in two male patients, a child and an adult, are described. Apoprotein B was absent in both cases and each patient had > 50% acanthocytes present on peripheral blood smear. Family studies revealed normal lipid profiles in the parents of both patients, which is consistent with the usual autosomal recessive inheritance of this disorder. In addition to a low-fat diet, both patients have been maintained on high doses of vitamins A and E. In the adult patient, detailed evaluations over a five-year period have failed to show any progression of neurological disease while maintained on high-dose vitamins. The role of supplemental vitamins A and E in the therapy of abetalipoprotenemia is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7425890     DOI: 10.1001/archneur.1980.00500590083015

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

Review 1.  Management of inherited outer retinal dystrophies: present and future.

Authors:  N H Chong; A C Bird
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

2.  Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome.

Authors:  R C Tripathi; B J Tripathi; S C Bauserman; J K Park
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Arrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapy.

Authors:  R A Hegele; A Angel
Journal:  Can Med Assoc J       Date:  1985-01-01       Impact factor: 8.262

4.  Treatment of peripheral neuropathies.

Authors:  M Hallett; D Tandon; A Berardelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

5.  Liver fibrosis in a patient with familial homozygous hypobetalipoproteinaemia: possible role of vitamin supplementation.

Authors:  J Y Scoazec; M E Bouma; J F Roche; D Blache; N Verthier; G Feldmann; G Gay
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 6.  Genetic determinants of hepatic steatosis in man.

Authors:  Amanda J Hooper; Leon A Adams; John R Burnett
Journal:  J Lipid Res       Date:  2011-01-18       Impact factor: 5.922

Review 7.  Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management.

Authors:  Jooho Lee; Robert A Hegele
Journal:  J Inherit Metab Dis       Date:  2013-11-28       Impact factor: 4.982

8.  Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.

Authors:  O Helk; R Schreiber; K Widhalm
Journal:  Eur J Clin Nutr       Date:  2016-05-18       Impact factor: 4.016

9.  Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes.

Authors:  M Raabe; L M Flynn; C H Zlot; J S Wong; M M Véniant; R L Hamilton; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 10.  Abetalipoproteinemia: two case reports and literature review.

Authors:  Rola Zamel; Razi Khan; Rebecca L Pollex; Robert A Hegele
Journal:  Orphanet J Rare Dis       Date:  2008-07-08       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.